SCHEMBL7225190

SCHEMBL7225190

COc1ccccc1C(O)c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 8/20 0.52
CYP3A4 P08684 4/20 0.52
ADORA2A P29274 6/20 0.52
ADORA1 P30542 6/20 0.52
ADORA3 P0DMS8 2/20 0.52
CYP2D6 P10635 2/20 0.52
SLC6A4 P31645 2/20 0.52
KDM4E B2RXH2 2/20 0.52
LMNA P02545 2/20 0.52
HTT P42858 2/20 0.52
ADORA2B P29275 1/20 0.52
CYP2C19 P33261 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.52
NR1I2 O75469 1/20 0.52
TP53 P04637 1/20 0.52
CYP1A2 P05177 1/20 0.52
HTR1A P08908 1/20 0.52
TSHR P16473 1/20 0.52
CNR1 P21554 1/20 0.52
GLRA1 P23415 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7225053 0.89 KCNH2 (0.61) KCNH2CYP3A4ADORA2AADORA1ADORA3
SCHEMBL10311174 0.85 KCNH2 (0.48) KCNH2CYP3A4ADORA2AADORA1ADORA3
SCHEMBL7227236 0.85 KCNH2 (0.54) KCNH2CYP3A4ADORA2AADORA1ADORA3
SCHEMBL7224943 0.84 KCNH2 (0.53) KCNH2CYP3A4ADORA2AADORA1ADORA3
SCHEMBL7218641 0.84 KCNH2 (0.53) KCNH2CYP3A4ADORA2AADORA1ADORA3
SCHEMBL7225691 0.84 KCNH2 (0.53) KCNH2CYP3A4ADORA2AADORA1ADORA3
SCHEMBL7225014 0.83 ADORA2A (0.63) KCNH2CYP3A4ADORA2AADORA1ADORA3
SCHEMBL7219159 0.83 ADORA2A (0.69) KCNH2CYP3A4ADORA2AADORA1ADORA3
SCHEMBL7219518 0.80 KCNH2 (0.48) KCNH2CYP3A4ADORA2AADORA1ADORA3
SCHEMBL8941191 0.79 KCNH2 (0.52) KCNH2CYP3A4ADORA2AADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583156-B1 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol VERNALIS RESEARCH LIMITED (GB) 2003-06-24 US claimed
EP-1107760-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2001-06-20 EP claimed
WO-2000013681-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2000-03-16 WO claimed
US-6583156-B1 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol VERNALIS RESEARCH LIMITED (GB) 2003-06-24 US disclosed
EP-1107760-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2001-06-20 EP disclosed
WO-2000013681-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2000-03-16 WO disclosed